Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized,Double-blind,Single-dosing,Crossover Study to Compare the Safety and Pharmacokinetic Characteristics of HD203 With Active Comparator

NCT01431404 is registered in ClinicalTrials.gov with Hanwha Chemical as lead sponsor.

NCT NCT01431404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01431404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized,Double-blind,Single-dosing,Crossover Study to Compare the Safety and Pharmacokinetic Characteristics of HD203 With Active Comparator
Lead sponsor
Hanwha Chemical
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2011
Completion date
June 30, 2013
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy